Holly M. Brothers
Neuroscience · The Ohio State University
Publications
36
Citations
2,014
Est. group size
—
Recurring co-author estimate
Active years
19
Publishing since 2007
Holly M. Brothers' research centers on Alzheimer's disease, particularly the role of amyloid-beta protein in the brain and the safety and effectiveness of drugs designed to reduce amyloid buildup, such as aducanumab. Her work includes both clinical trial analyses and broader reviews questioning how amyloid burden relates to cognitive decline and disease treatment strategies.
Publication activity has been sparse and irregular over the last decade, with clusters of output in 2018 and 2025 but no publications recorded in the intervening years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's disease
Alzheimer s & Dementia · 2025
- Lower baseline amyloid beta burden is associated with greater percent of amyloid beta positron emission tomography reduction and better clinical outcomes in the aducanumab Phase 3 trials ENGAGE and EMERGE in early Alzheimer's disease
The Journal of Prevention of Alzheimer s Disease · 2025
- The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
Frontiers in Aging Neuroscience · 2018
- Alzheimer’s Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence
Journal of Alzheimer s Disease · 2018
- Consequences of redefining Alzheimer's disease in terms of amyloid burden without regard to cognitive decline
Neural Regeneration Research · 2018
- Safety and Efficacy of Anti-Amyloid-β Immunotherapy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Journal of Neuroimmune Pharmacology · 2016
- Pharmacological Agents Targeting γ-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer’s Disease Patients: A Systematic Review and Meta-Analysis
Journal of Alzheimer s Disease · 2016
- P2‐004: Drugs Targeting Gamma‐Secretase Are Associated with Cognitive Decline and Elevated Risk of Skin Cancer: A Meta‐Analysis
Alzheimer s & Dementia · 2016
- P1‐043: Immunotherapy Targeting Amyloid‐Beta in Alzheimer's Disease: A Meta‐Analysis
Alzheimer s & Dementia · 2016
- Alzheimer s & Dementia×3
- Journal of Alzheimer s Disease×2
- Frontiers in Aging Neuroscience×1
- Brain Behavior and Immunity×1
- Journal of Neuroimmune Pharmacology×1
- Jie Gao
Neuroscience · The Ohio State University
- Nicole D. Schartz
Neuroscience · Purdue University West Lafayette
- Andy P. Tsai
Neuroscience · Indiana University
- Luke C. Dabin
Neuroscience · Indiana University
- Malú G. Tansey
Neuroscience · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile